Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aggregated n-of-1 randomized trial of nebulized fentanyl vs nebulized furosemide for refractory breathlessness in palliative care
TCTR20210705003Phase 2Completed
- Sponsor
- No
- Start
- Jan 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fentanyl, furosemide in Chronic breathlessness syndrome, sponsored by No. Started Jan 2019; status: completed.
02
Drugs
fentanylfurosemide
03
Conditions
Chronic breathlessness syndrome
Beyond the preview
Go deeper on TCTR20210705003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210705003.